Heron Therapeutics Inc vs Vanguard S&P 500 Growth Index Fund ETF — how do they compare? Heron Therapeutics Inc trades at $0.32 (market cap $61.47M), while Vanguard S&P 500 Growth Index Fund ETF trades at $85.24. The key difference: Vanguard S&P 500 Growth Index Fund ETF is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| HRTX | VOOG | |
|---|---|---|
Market Cap | $61.47M | — |
Sector | Health | Broad Market / Factor |
52-Week High | $1.49 | $85.42 |
52-Week Low | $0.32 | $65.32 |
Enterprise Value | $168.21M | — |
Trailing returns across standard periods
Latest headlines on both assets
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →VOOG is an index-based ETF that tracks the S&P 500 Growth Index, composed of the growth-oriented companies within the S&P 500. It selects constituents based on three key metrics—sales growth, the ratio of earnings change to price, and momentum—offering a highly liquid and low-cost way to capture the high-performing 'growth slice' of the broader U.S. large-cap market.
Read more on VOOG →